FDA Inspection
AltaSciences Clinical Los Angeles Inc.AltaSciences Clinical Los Angeles Inc. – FDA Inspection, Mar 24, 2017
Record Details
This FDA Inspection record concerns AltaSciences Clinical Los Angeles Inc., with an inspection on March 24, 2017, issued by the Los Angeles District Office, covering human drugs.
- Person
- Yvonne T. Lacour (Issuing Officer)
View Company Profile
ID · 311733d7-7367-4060-a1ff-bc086c2efb90
Inspection Facts
- Inspection number
- 1005233
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AltaSciences Clinical Los Angeles Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 18, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 4, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 24, 2017 | Not classified | Los Angeles District Office | |
| March 24, 2017 | Not classified | Los Angeles District Office |
Other documents for AltaSciences Clinical Los Angeles Inc.
- FDA Inspection 1174519 - 2022-06-30
- FDA Inspection 1144217 - 2021-06-18
- FDA Inspection 1102096 - 2019-09-04
- FDA Inspection 1008799 - 2017-03-24
- FDA Inspection 1008784 - 2017-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.